Email
Print
Opioids Market Overview:
The Opioids Market size is estimated to reach $620 Million by 2030, growing at a CAGR of 4% during the forecast period 2023-2030. The opioids market revolves around pharmaceutical products derived from opium, used primarily for pain management. Opioids act on the central nervous system's receptors to alleviate pain, but they also carry a risk of addiction and abuse.
The market includes various forms such as prescription painkillers, synthetic opioids, and illicit drugs like heroin. Despite their effectiveness, concerns over opioid misuse have driven efforts to balance accessibility with safety.
Regulatory measures, public health campaigns, and the development of abuse-deterrent formulations have shaped the market's dynamics. Opioid-related overdoses and addiction have also prompted increased attention on alternative pain management strategies and the expansion of addiction treatment services. As the market continues to evolve, stakeholders seek to strike a balance between addressing pain needs and mitigating the opioid epidemic's adverse effects.
Market Snapshot:
Opioids Market - Report Coverage:
The “Opioids Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Opioids Market.
| Attribute | Segment |
|---|---|
BY PRODUCT TYPE |
|
BY APPLICATION |
|
By Geography |
|
Opioids Market - Top Trends Technological advancements:
Abuse-Deterrent Formulations: Pharmaceutical companies are investing in the development of opioids with abuse-deterrent properties. These formulations make it more difficult for individuals to tamper with the medication to achieve a rapid and intense high, thereby reducing the risk of misuse.
Telemedicine and Digital Health: Telemedicine platforms and digital health solutions are being utilized to enhance pain management. Patients can consult healthcare providers remotely, receive prescription refills, and access personalized pain management plans, reducing the need for in-person visits and improving patient outcomes.
Precision Medicine: Advances in genetic and molecular research are enabling the exploration of precision medicine approaches for pain management. Tailoring opioid prescriptions based on individual genetic factors can optimize pain relief while minimizing the risk of adverse effects and addiction.
Big Data and Analytics: Healthcare providers are leveraging big data and analytics to identify patterns of opioid prescribing, usage, and abuse. This data-driven approach helps healthcare systems and policymakers make informed decisions to address the opioid epidemic.
Nanotechnology: Nanotechnology is being explored to create opioid formulations that release the medication gradually and target specific pain receptors, potentially reducing the risk of overdose and dependency.
Opioids Market - Company Product Analysis
Dosage Forms: Dosage Forms is available in various dosage forms, such as tablets, capsules, patches, or injectables, providing healthcare providers with flexibility in tailoring treatment to patients' needs.
Indications: Indications is indicated for the management of [specific pain conditions], catering to a wide range of patients experiencing different types of pain.
Dosing Regimen: The Dosing Regimen offers a dosing regimen that balances effective pain relief with minimizing potential side effects and risks associated with opioid therapy.
Patient Education: Patient Education offers comprehensive educational resources for patients and healthcare providers, including information about proper use, potential side effects, and responsible storage and disposal of opioids.
Formulation Innovation: Formulation Innovation has invested in developing formulations that enhance patient adherence and safety, including extended-release formulations or abuse-deterrent technologies.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Opioids Market. The top 10 companies in this industry are listed below:
| Report Metric | Details |
|---|---|
Base Year Considered | 2022 |
Forecast Period | 2023–2030 |
CAGR | 4% |
Market Size in 2030 | $620 Million |
Segments Covered | By Treatment Type, Distribution Channel, Route of Administration, End User and Region |
Geographies Covered | North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
Key Market Players |
|
Table of Contents
1. Opioids Market - Overview
1.1. Definitions and Scope
2. Opioids Market - Executive Summary
3. Opioids Market - Comparative Analysis
3.1. Company Benchmarking - Key Companies
3.2. Global Financial Analysis - Key Companies
3.3. Market Share Analysis - Key Companies
3.4. Patent Analysis
3.5. Pricing Analysis
4. Opioids Market - Start-up Companies Scenario
4.1. Key Start-up Company Analysis by
4.2. Investment
4.3. Revenue
4.4. Venture Capital and Funding Scenario
5. Opioids Market – Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing Business Index
5.3. Case Studies of Successful Ventures
6. Opioids Market - Forces
6.1. Market Drivers
6.2. Market Constraints
6.3. Market Challenges
6.4. Porter's Five Force Model
6.5. Bargaining Power of Suppliers
6.6. Bargaining Powers of Customers
6.7. Threat of New Entrants
6.8. Rivalry Among Existing Players
6.9. Threat of Substitutes
7. Opioids Market – Strategic Analysis
7.1. Value Chain Analysis
7.2. Opportunities Analysis
7.3. Market Life Cycle
8. Opioids Market – BY PRODUCT TYPE (Market Size – $Million/$Billion)
8.1. Methadone
8.1.1. Market Size and Forecast, By Region
8.1.2. Market Share Analysis, By Country
8.2. A Codeine
8.2.1. Market Size and Forecast, By Region
8.2.2. Market Share Analysis, By Country
8.3. Fentanyl
8.3.1. Market Size and Forecast, By Region
8.3.2. Market Share Analysis, By Country
8.4. Oxycodone
8.4.1. Market Size and Forecast, By Region
8.4.2. Market Share Analysis, By Country
8.5. Morphine
8.5.1. Market Size and Forecast, By Region
8.5.2. Market Share Analysis, By Country
8.6. Hydrocodone
8.6.1. Market Size and Forecast, By Region
8.6.2. Market Share Analysis, By Country
9. Opioids Market – BY APPLICATION (Market Size – $Million/$Billion)
9.1. Pain Management
9.1.1. Market Size and Forecast, By Region
9.1.2. Market Share Analysis, By Country
9.2. Cough Treatment
9.2.1. Market Size and Forecast, By Region
9.2.2. Market Share Analysis, By Country
9.3. Diarrhea Treatment
9.3.1. Market Size and Forecast, By Region
9.3.2. Market Share Analysis, By Country
10. Opioids Market – by Geography (Market Size – $Million/$Billion)
10.1. North America
10.1.1. The U.S.
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. UK
10.2.2. Germany
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Chile
10.4.4. Colombia
10.4.5. Rest of South America
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
11. Opioids Market – Entropy
12. Opioids Market – Industry/Segment Competition Landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Product Type – Key Companies
12.1.2. Market Share by Region – Key Companies
12.1.3. Market Share by Country – Key Companies
12.2. Competition Matrix
12.3. Best Practices for Companies
13. Opioids Market – Key Company List by Country Premium Premium
14. Opioids Market - Company Analysis
14.1. Purdue Pharma LP
14.2. AstraZeneca Plc
14.3. C.H. Boehringer Sohn Ag and Ko. Kg
14.4. Johnson & Johnson, Inc..
14.5. Sanofi S.A.
14.6. Mallinckrodt Pharmaceuticals
14.7. Endo Pharmaceuticals Inc
14.8. Teva Pharmaceutical Industries Limited
14.9. Pfizer, Inc.
14.10. Sun Pharmaceuticals
14.11. Hikma Pharmaceuticals PLC
14.12. AbbVie Inc.
14.13. Grünenthal
14.14. Merck & Co., Inc.
14.15. Boehringer Ingelheim international GmbH
14.16. Janssen pharmaceuticals,inc.
14.17. Mallinckrodt pharmaceuticals
14.18. Endo pharmaceuticals inc.
14.19. Assertio therapeutics, inc.
14.20. Reckitt Benckiser Group plc
• "Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our
reports include global-level data, niche markets and competitive landscape.
LIST OF TABLES
1.Global Opioids Market-Competitive Analysis Market 2023-2030 ($M)1.1 Company/Competition Categorization Market 2023-2030 ($M) - Global Industry Research
1.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
1.1.2 Key company market share analysis, Market 2023-2030 ($M)
1.2 Public Companies Market 2023-2030 ($M) - Global Industry Research
1.2.1 Company market share Market 2023-2030 ($M)
1.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
1.3 Private Companies Market 2023-2030 ($M) - Global Industry Research
1.3.1 List of key emerging companies Market 2023-2030 ($M)
2.Global Competitive Landscape Market 2023-2030 ($M)
2.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Global Industry Research
2.1.1 Company size Market 2023-2030 ($M)
2.1.2 Distribution network Market 2023-2030 ($M)
2.1.3 Segment coverage Market 2023-2030 ($M)
2.1.4 Geographic presence Market 2023-2030 ($M)
2.1.5 Collaborations Market 2023-2030 ($M)
2.2 Purdue Pharma L.P Market 2023-2030 ($M) - Global Industry Research
2.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Global Industry Research
2.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Global Industry Research
2.5 Pfizer, Inc. Market 2023-2030 ($M) - Global Industry Research
2.6 ALLERGAN Market 2023-2030 ($M) - Global Industry Research
2.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Global Industry Research
2.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Global Industry Research
2.9 Grunenthal GmbH Market 2023-2030 ($M) - Global Industry Research
3.Global Opioids Market-Competitive Analysis Market 2023-2030 (Volume/Units)
3.1 Company/Competition Categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 List of key distributors and channel partners Market 2023-2030 (Volume/Units)
3.1.2 Key company market share analysis, Market 2023-2030 (Volume/Units)
3.2 Public Companies Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Company market share Market 2023-2030 (Volume/Units)
3.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 (Volume/Units)
3.3 Private Companies Market 2023-2030 (Volume/Units) - Global Industry Research
3.3.1 List of key emerging companies Market 2023-2030 (Volume/Units)
4.Global Competitive Landscape Market 2023-2030 (Volume/Units)
4.1 Heat Map Analysis of Private Companies Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Company size Market 2023-2030 (Volume/Units)
4.1.2 Distribution network Market 2023-2030 (Volume/Units)
4.1.3 Segment coverage Market 2023-2030 (Volume/Units)
4.1.4 Geographic presence Market 2023-2030 (Volume/Units)
4.1.5 Collaborations Market 2023-2030 (Volume/Units)
4.2 Purdue Pharma L.P Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Pfizer, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
4.6 ALLERGAN Market 2023-2030 (Volume/Units) - Global Industry Research
4.7 Sanofi-Aventis S.A. Market 2023-2030 (Volume/Units) - Global Industry Research
4.8 Sun Pharmaceutical Industries Limited Market 2023-2030 (Volume/Units) - Global Industry Research
4.9 Grunenthal GmbH Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Opioids Market-Competitive Analysis Market 2023-2030 ($M)
5.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
5.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
5.1.2 Key company market share analysis, Market 2023-2030 ($M)
5.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Company market share Market 2023-2030 ($M)
5.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
5.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
5.3.1 List of key emerging companies Market 2023-2030 ($M)
6.North America Competitive Landscape Market 2023-2030 ($M)
6.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Company size Market 2023-2030 ($M)
6.1.2 Distribution network Market 2023-2030 ($M)
6.1.3 Segment coverage Market 2023-2030 ($M)
6.1.4 Geographic presence Market 2023-2030 ($M)
6.1.5 Collaborations Market 2023-2030 ($M)
6.2 Purdue Pharma L.P Market 2023-2030 ($M) - Regional Industry Research
6.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Regional Industry Research
6.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Regional Industry Research
6.5 Pfizer, Inc. Market 2023-2030 ($M) - Regional Industry Research
6.6 ALLERGAN Market 2023-2030 ($M) - Regional Industry Research
6.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Regional Industry Research
6.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Regional Industry Research
6.9 Grunenthal GmbH Market 2023-2030 ($M) - Regional Industry Research
7.South America Opioids Market-Competitive Analysis Market 2023-2030 ($M)
7.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
7.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
7.1.2 Key company market share analysis, Market 2023-2030 ($M)
7.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Company market share Market 2023-2030 ($M)
7.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
7.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
7.3.1 List of key emerging companies Market 2023-2030 ($M)
8.South America Competitive Landscape Market 2023-2030 ($M)
8.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Regional Industry Research
8.1.1 Company size Market 2023-2030 ($M)
8.1.2 Distribution network Market 2023-2030 ($M)
8.1.3 Segment coverage Market 2023-2030 ($M)
8.1.4 Geographic presence Market 2023-2030 ($M)
8.1.5 Collaborations Market 2023-2030 ($M)
8.2 Purdue Pharma L.P Market 2023-2030 ($M) - Regional Industry Research
8.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Regional Industry Research
8.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Regional Industry Research
8.5 Pfizer, Inc. Market 2023-2030 ($M) - Regional Industry Research
8.6 ALLERGAN Market 2023-2030 ($M) - Regional Industry Research
8.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Regional Industry Research
8.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Regional Industry Research
8.9 Grunenthal GmbH Market 2023-2030 ($M) - Regional Industry Research
9.Europe Opioids Market-Competitive Analysis Market 2023-2030 ($M)
9.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
9.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
9.1.2 Key company market share analysis, Market 2023-2030 ($M)
9.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Company market share Market 2023-2030 ($M)
9.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
9.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
9.3.1 List of key emerging companies Market 2023-2030 ($M)
10.Europe Competitive Landscape Market 2023-2030 ($M)
10.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Company size Market 2023-2030 ($M)
10.1.2 Distribution network Market 2023-2030 ($M)
10.1.3 Segment coverage Market 2023-2030 ($M)
10.1.4 Geographic presence Market 2023-2030 ($M)
10.1.5 Collaborations Market 2023-2030 ($M)
10.2 Purdue Pharma L.P Market 2023-2030 ($M) - Regional Industry Research
10.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Regional Industry Research
10.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Regional Industry Research
10.5 Pfizer, Inc. Market 2023-2030 ($M) - Regional Industry Research
10.6 ALLERGAN Market 2023-2030 ($M) - Regional Industry Research
10.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Regional Industry Research
10.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Regional Industry Research
10.9 Grunenthal GmbH Market 2023-2030 ($M) - Regional Industry Research
11.APAC Opioids Market-Competitive Analysis Market 2023-2030 ($M)
11.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
11.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
11.1.2 Key company market share analysis, Market 2023-2030 ($M)
11.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Company market share Market 2023-2030 ($M)
11.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
11.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
11.3.1 List of key emerging companies Market 2023-2030 ($M)
12.APAC Competitive Landscape Market 2023-2030 ($M)
12.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Company size Market 2023-2030 ($M)
12.1.2 Distribution network Market 2023-2030 ($M)
12.1.3 Segment coverage Market 2023-2030 ($M)
12.1.4 Geographic presence Market 2023-2030 ($M)
12.1.5 Collaborations Market 2023-2030 ($M)
12.2 Purdue Pharma L.P Market 2023-2030 ($M) - Regional Industry Research
12.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Regional Industry Research
12.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Regional Industry Research
12.5 Pfizer, Inc. Market 2023-2030 ($M) - Regional Industry Research
12.6 ALLERGAN Market 2023-2030 ($M) - Regional Industry Research
12.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Regional Industry Research
12.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Regional Industry Research
12.9 Grunenthal GmbH Market 2023-2030 ($M) - Regional Industry Research
13.MENA Opioids Market-Competitive Analysis Market 2023-2030 ($M)
13.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
13.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
13.1.2 Key company market share analysis, Market 2023-2030 ($M)
13.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Company market share Market 2023-2030 ($M)
13.2.2 Synergy analysis:Major deals strategic alliances Market 2023-2030 ($M)
13.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
13.3.1 List of key emerging companies Market 2023-2030 ($M)
14.MENA Competitive Landscape Market 2023-2030 ($M)
14.1 Heat Map Analysis of Private Companies Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Company size Market 2023-2030 ($M)
14.1.2 Distribution network Market 2023-2030 ($M)
14.1.3 Segment coverage Market 2023-2030 ($M)
14.1.4 Geographic presence Market 2023-2030 ($M)
14.1.5 Collaborations Market 2023-2030 ($M)
14.2 Purdue Pharma L.P Market 2023-2030 ($M) - Regional Industry Research
14.3 Janssen Pharmaceuticals, Inc. Market 2023-2030 ($M) - Regional Industry Research
14.4 West-Ward Pharmaceuticals Corporation Market 2023-2030 ($M) - Regional Industry Research
14.5 Pfizer, Inc. Market 2023-2030 ($M) - Regional Industry Research
14.6 ALLERGAN Market 2023-2030 ($M) - Regional Industry Research
14.7 Sanofi-Aventis S.A. Market 2023-2030 ($M) - Regional Industry Research
14.8 Sun Pharmaceutical Industries Limited Market 2023-2030 ($M) - Regional Industry Research
14.9 Grunenthal GmbH Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Opioids Market Revenue, 2023-2030 ($M)2.Canada Opioids Market Revenue, 2023-2030 ($M)
3.Mexico Opioids Market Revenue, 2023-2030 ($M)
4.Brazil Opioids Market Revenue, 2023-2030 ($M)
5.Argentina Opioids Market Revenue, 2023-2030 ($M)
6.Peru Opioids Market Revenue, 2023-2030 ($M)
7.Colombia Opioids Market Revenue, 2023-2030 ($M)
8.Chile Opioids Market Revenue, 2023-2030 ($M)
9.Rest of South America Opioids Market Revenue, 2023-2030 ($M)
10.UK Opioids Market Revenue, 2023-2030 ($M)
11.Germany Opioids Market Revenue, 2023-2030 ($M)
12.France Opioids Market Revenue, 2023-2030 ($M)
13.Italy Opioids Market Revenue, 2023-2030 ($M)
14.Spain Opioids Market Revenue, 2023-2030 ($M)
15.Rest of Europe Opioids Market Revenue, 2023-2030 ($M)
16.China Opioids Market Revenue, 2023-2030 ($M)
17.India Opioids Market Revenue, 2023-2030 ($M)
18.Japan Opioids Market Revenue, 2023-2030 ($M)
19.South Korea Opioids Market Revenue, 2023-2030 ($M)
20.South Africa Opioids Market Revenue, 2023-2030 ($M)
21.North America Opioids By Application
22.South America Opioids By Application
23.Europe Opioids By Application
24.APAC Opioids By Application
25.MENA Opioids By Application
The Motion Sickness Treatment is forecast to grow at 4% during the forecast period 2023-2030.
Global Opioids Market size is estimated to reach $620 Million by 2030.
The leading players in the Opioids Market are Purdue Pharma LP, AstraZeneca Plc., C.H. Boehringer Sohn Ag and Ko. Kg , Johnson & Johnson, Inc.., Sanofi S.A.